Sfoglia per Autore
Angiogenic growth factor-endothelial cell interaction: receptor binding and cell internalization techniques
2003-01-01 Urbinati, Chiara Eva; L., Tassone; Bugatti, Antonella; M., Camozzi; Rusnati, Marco
HIV-1 Tat e iL monocita/macrofago: dall'interazione cellula/proteina all'insorgenza delle patologie associate all'AIDS
2003-01-01 Rusnati, Marco; Tassone, L.; Urbinati, Chiara Eva
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists.
2004-01-01 Urbinati, Chiara Eva; Bugatti, Antonella; P., Oreste; G., Zoppetti; J., Waltenberger; Mitola, Stefania Maria Filomena; D., Ribatti; Presta, Marco; Rusnati, Marco
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists.
2005-01-01 Presta, Marco; Oreste, P; Zoppetti, G; Belleri, Mirella; Tanghetti, Elena; Leali, D; Urbinati, Chiara Eva; Bugatti, Antonella; Ronca, Roberto; Nicoli, S; Moroni, Emanuela; Stabile, H; Camozzi, Maura; Hernandez, Ga; Mitola, Stefania Maria Filomena; Dell'Era, Patrizia; Rusnati, Marco; Ribatti, D.
alpha v beta 3 integrin-dependent activation of focal adhesion kinase mediates NF-kB activation and motogenic activity by HIV-1 Tat in endothelial cells
2005-01-01 Urbinati, Chiara Eva; Bugatti, Antonella; M., Giacca; D., Schlaepfer; Presta, Marco; Rusnati, Marco
Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo.
2005-01-01 Urbinati, Chiara Eva; Mitola, Stefania Maria Filomena; Tanghetti, Elena; Kumar, C; Waltenberger, J; Ribatti, D; Presta, Marco; Rusnati, Marco
Cutting edge: proangiogenic properties of alternatively activated dendritic cells.
2005-01-01 Riboldi, Elena; T., Musso; Moroni, Emanuela; Urbinati, Chiara Eva; S., Bernasconi; Rusnati, Marco; L., Adorini; Presta, Marco; Sozzani, Silvano
Glycomics and angiogenesis: biological implications and therapeutical exploiting
2006-01-01 Rusnati, Marco; Urbinati, Chiara Eva; Presta, Marco
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine.
2006-01-01 Mitola, Stefania Maria Filomena; Belleri, Mirella; Urbinati, Chiara Eva; Coltrini, Daniela; Sparatore, B; Pedrazzi, M; Melloni, E; Presta, Marco
endothelial cell adhesion to HIV-1 Tat: cross talk between integrin alphav beta3 and vascular endothelial growth factor receptor-2 (KDR)
2007-01-01 Urbinati, Chiara Eva; Ravelli, Cosetta; Bugatti, Antonella; Presta, Marco; Rusnati, Marco
Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of HIV-1 Tat and gp120 proteins
2007-01-01 Bugatti, Antonella; Urbinati, Chiara Eva; Ravelli, Cosetta; E., Declerq; S., Liekens; Rusnati, Marco
Polyanionic drugs and viral oncogenesis: a novel approach to control virus infection, tumor-associated inflammation and angiogenesis
2008-01-01 Urbinati, Chiara Eva; Chiodelli, Paola; Rusnati, Marco
Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain
2008-01-01 Margosio, B; Rusnati, Marco; Bonezzi, K; CORDES B., La; Annis, Dsa; Urbinati, Chiara Eva; Giavazzi, R; Presta, Marco; Ribatti, D; Mosher, Df; Taraboletti, G.
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody
2009-01-01 Ronca, Roberto; Benzoni, P.; Gualandi, Laura; Belleri, Mirella; Leali, Daria; Tobia, Chiara; Urbinati, Chiara Eva; Corsini, M.; Presta, Marco; Dell'Era, Patrizia
HIV-1 Tat and heparan sulfate proteoglycan interact to mediate lymphocyte adhesion and migration across the endothelium
2009-01-01 Rusnati, Marco; Stefania, Nicoli; Guido, David; Mauro, Giacca; Presta, Marco; Urbinati, Chiara Eva
Inhibition of HIV-Tat angiogenic activity targeting HSPGs biosynthesis enzymes
2009-01-01 Urbinati, Chiara Eva; Giancarlo, Ghiselli; Grillo, Elisabetta; Rusnati, Marco
Role of Syndecan-1 in HIV-1 Tat-induced chemotaxis of lymphoid cells
2009-01-01 Urbinati, Chiara Eva; Emanuela, Romano; Guido, David; Rusnati, Marco
HIV-1 Tat and heparan sulfate proteoglycans: a novel mechanism of lymphocyte adhesion and migration across the endothelium
2009-01-01 Urbinati, Chiara Eva; S., Nicoli; M., Giacca; G., David; Fiorentini, Simona; Caruso, Arnaldo; M., Alfano; L., Cassetta; Presta, Marco; Rusnati, Marco
Polysulfated/sulfonated compounds for the development of drugs at the crossroad of viral infection and oncogenesis
2009-01-01 Rusnati, Marco; Urbinati, Chiara Eva
VEGFR2 and v3 recruitment and cross-talk at the basal aspect of HIV-1 Tat-adherent endothelial cells drives pp60src/ERK1/2 activation, cytoskeleton organization and pro-angiogenic activation
2010-01-01 Urbinati, Chiara Eva; Ravelli, Cosetta; Giacopuzzi, Edoardo; Monti, Eugenio; Rusnati, Marco
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Angiogenic growth factor-endothelial cell interaction: receptor binding and cell internalization techniques | 1-gen-2003 | Urbinati, Chiara Eva; L., Tassone; Bugatti, Antonella; M., Camozzi; Rusnati, Marco | |
HIV-1 Tat e iL monocita/macrofago: dall'interazione cellula/proteina all'insorgenza delle patologie associate all'AIDS | 1-gen-2003 | Rusnati, Marco; Tassone, L.; Urbinati, Chiara Eva | |
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. | 1-gen-2004 | Urbinati, Chiara Eva; Bugatti, Antonella; P., Oreste; G., Zoppetti; J., Waltenberger; Mitola, Stefania Maria Filomena; D., Ribatti; Presta, Marco; Rusnati, Marco | |
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. | 1-gen-2005 | Presta, Marco; Oreste, P; Zoppetti, G; Belleri, Mirella; Tanghetti, Elena; Leali, D; Urbinati, Chiara Eva; Bugatti, Antonella; Ronca, Roberto; Nicoli, S; Moroni, Emanuela; Stabile, H; Camozzi, Maura; Hernandez, Ga; Mitola, Stefania Maria Filomena; Dell'Era, Patrizia; Rusnati, Marco; Ribatti, D. | |
alpha v beta 3 integrin-dependent activation of focal adhesion kinase mediates NF-kB activation and motogenic activity by HIV-1 Tat in endothelial cells | 1-gen-2005 | Urbinati, Chiara Eva; Bugatti, Antonella; M., Giacca; D., Schlaepfer; Presta, Marco; Rusnati, Marco | |
Integrin {alpha}V{beta}3 as a Target for Blocking HIV-1 Tat-Induced Endothelial Cell Activation In Vitro and Angiogenesis In Vivo. | 1-gen-2005 | Urbinati, Chiara Eva; Mitola, Stefania Maria Filomena; Tanghetti, Elena; Kumar, C; Waltenberger, J; Ribatti, D; Presta, Marco; Rusnati, Marco | |
Cutting edge: proangiogenic properties of alternatively activated dendritic cells. | 1-gen-2005 | Riboldi, Elena; T., Musso; Moroni, Emanuela; Urbinati, Chiara Eva; S., Bernasconi; Rusnati, Marco; L., Adorini; Presta, Marco; Sozzani, Silvano | |
Glycomics and angiogenesis: biological implications and therapeutical exploiting | 1-gen-2006 | Rusnati, Marco; Urbinati, Chiara Eva; Presta, Marco | |
Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. | 1-gen-2006 | Mitola, Stefania Maria Filomena; Belleri, Mirella; Urbinati, Chiara Eva; Coltrini, Daniela; Sparatore, B; Pedrazzi, M; Melloni, E; Presta, Marco | |
endothelial cell adhesion to HIV-1 Tat: cross talk between integrin alphav beta3 and vascular endothelial growth factor receptor-2 (KDR) | 1-gen-2007 | Urbinati, Chiara Eva; Ravelli, Cosetta; Bugatti, Antonella; Presta, Marco; Rusnati, Marco | |
Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of HIV-1 Tat and gp120 proteins | 1-gen-2007 | Bugatti, Antonella; Urbinati, Chiara Eva; Ravelli, Cosetta; E., Declerq; S., Liekens; Rusnati, Marco | |
Polyanionic drugs and viral oncogenesis: a novel approach to control virus infection, tumor-associated inflammation and angiogenesis | 1-gen-2008 | Urbinati, Chiara Eva; Chiodelli, Paola; Rusnati, Marco | |
Fibroblast growth factor-2 binding to the thrombospondin-1 type III repeats, a novel antiangiogenic domain | 1-gen-2008 | Margosio, B; Rusnati, Marco; Bonezzi, K; CORDES B., La; Annis, Dsa; Urbinati, Chiara Eva; Giavazzi, R; Presta, Marco; Ribatti, D; Mosher, Df; Taraboletti, G. | |
Isolation and characterization of a neutralizing and anti-angiogenic anti-FGFR1 single chain antibody | 1-gen-2009 | Ronca, Roberto; Benzoni, P.; Gualandi, Laura; Belleri, Mirella; Leali, Daria; Tobia, Chiara; Urbinati, Chiara Eva; Corsini, M.; Presta, Marco; Dell'Era, Patrizia | |
HIV-1 Tat and heparan sulfate proteoglycan interact to mediate lymphocyte adhesion and migration across the endothelium | 1-gen-2009 | Rusnati, Marco; Stefania, Nicoli; Guido, David; Mauro, Giacca; Presta, Marco; Urbinati, Chiara Eva | |
Inhibition of HIV-Tat angiogenic activity targeting HSPGs biosynthesis enzymes | 1-gen-2009 | Urbinati, Chiara Eva; Giancarlo, Ghiselli; Grillo, Elisabetta; Rusnati, Marco | |
Role of Syndecan-1 in HIV-1 Tat-induced chemotaxis of lymphoid cells | 1-gen-2009 | Urbinati, Chiara Eva; Emanuela, Romano; Guido, David; Rusnati, Marco | |
HIV-1 Tat and heparan sulfate proteoglycans: a novel mechanism of lymphocyte adhesion and migration across the endothelium | 1-gen-2009 | Urbinati, Chiara Eva; S., Nicoli; M., Giacca; G., David; Fiorentini, Simona; Caruso, Arnaldo; M., Alfano; L., Cassetta; Presta, Marco; Rusnati, Marco | |
Polysulfated/sulfonated compounds for the development of drugs at the crossroad of viral infection and oncogenesis | 1-gen-2009 | Rusnati, Marco; Urbinati, Chiara Eva | |
VEGFR2 and v3 recruitment and cross-talk at the basal aspect of HIV-1 Tat-adherent endothelial cells drives pp60src/ERK1/2 activation, cytoskeleton organization and pro-angiogenic activation | 1-gen-2010 | Urbinati, Chiara Eva; Ravelli, Cosetta; Giacopuzzi, Edoardo; Monti, Eugenio; Rusnati, Marco |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile